查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1728308

青黴素 G 鈉市場 - 全球產業規模、佔有率、趨勢、機會和預測，按銷售管道、最終用途、地區和競爭細分，2020-2030 年

Penicillin G Sodium Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel, By End Use, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球青黴素 G 鈉市值為 2.5921 億美元，預計到 2030 年將達到 3.9733 億美元，預測期內複合年成長率為 4.80%。青黴素G鈉是青黴素家族中重要的注射用抗生素，在治療敏感菌引起的細菌感染中起著至關重要的作用。在製藥製造業的進步和良好生產規範 (GMP) 的遵守的支持下，其在臨床環境中的廣泛應用繼續推動市場需求。對生產品質和法規遵循的重視確保注射青黴素製劑符合安全性和有效性的國際標準。

市場概覽
預測期 2026-2030
2024年市場規模 2.5921億美元
2030年市場規模 3.9733億美元
2025-2030 年複合年成長率 4.80%
成長最快的領域 直接的
最大的市場 亞太地區

醫療支出的增加、傳染病發病率的上升以及政府主導的旨在擴大救命藥物獲取管道的舉措進一步刺激了市場的發展。儘管如此，原料價格波動、依賴基於發酵的生產過程以及週期性的供應鏈中斷等挑戰也構成了限制因素。此外，人們對抗生素抗藥性的日益擔憂以及一些地區更嚴格的處方規定可能會限制抗生素的使用，特別是在控制抗生素過度使用方面。

關鍵市場促進因素

製藥業的成長

主要市場挑戰

原物料價格波動

主要市場趨勢

合約製造組織（CMO）的擴張

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：COVID-19 對全球青黴素 G 鈉市場的影響

第5章：全球青黴素G鈉市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按銷售管道（直接、間接）
    • 依最終用途（細菌感染、梅毒、預防、腦膜炎、聯合療法、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美青黴素G鈉市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲青黴素G鈉市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太青黴素G鈉市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美青黴素G鈉市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲青黴素G鈉市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第 13 章：全球青黴素 G 鈉市場：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • North China Pharmaceutical Company.Ltd
  • Henan Xinxiang Huaxing Pharmaceutical
  • CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD.
  • Shandong Lukang Pharmaceutical Group Co., Ltd.
  • Kangyuan Pharmaceutical Group
  • Harbin Pharmaceutical Group

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 28999

The Global Penicillin G Sodium Market was valued at USD 259.21 Million in 2024 and is projected to reach USD 397.33 Million by 2030, growing at a CAGR of 4.80% during the forecast period. Penicillin G Sodium, an essential injectable antibiotic in the penicillin family, plays a critical role in treating bacterial infections caused by susceptible organisms. Its widespread application in clinical settings continues to drive market demand, supported by advancements in pharmaceutical manufacturing and adherence to Good Manufacturing Practices (GMP). The emphasis on production quality and regulatory compliance ensures that injectable penicillin formulations meet international standards for safety and efficacy.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 259.21 Million
Market Size 2030USD 397.33 Million
CAGR 2025-20304.80%
Fastest Growing SegmentDirect
Largest MarketAsia Pacific

The market is further stimulated by rising healthcare spending, increasing incidences of infectious diseases, and government-led initiatives focused on expanding access to life-saving medications. Nonetheless, challenges such as raw material price fluctuations, reliance on fermentation-based production processes, and periodic supply chain interruptions pose constraints. Additionally, growing concerns over antibiotic resistance and tighter prescribing protocols in some regions may temper usage, particularly in efforts to control antimicrobial overuse.

Key Market Drivers

Growth in Pharmaceutical Industry

The global pharmaceutical sector's expansion-particularly in emerging markets such as Asia-Pacific, Africa, and Latin America-is a major driver of demand for Penicillin G Sodium. The industry reached approximately USD 1.6 trillion in revenue by 2023, positioning it alongside the GDP of countries like Mexico or Australia. This robust growth reflects broader access to healthcare, improved medical infrastructure, and heightened health awareness. In these regions, governments and health providers are prioritizing low-cost, effective treatment options. Penicillin G Sodium, known for its reliability and affordability, remains a frontline therapy in combating bacterial infections and is widely included in public health procurement strategies.

Key Market Challenges

Volatility in Raw Material Prices

Price instability in key raw materials poses a significant challenge to the Penicillin G Sodium market. The fermentation-based production of this antibiotic depends on raw materials like corn steep liquor, lactose, and glucose-substances sensitive to agricultural yields, energy prices, and geopolitical disruptions. Any variation in the cost or supply of these inputs can directly impact manufacturing expenses. Manufacturers are particularly vulnerable to spikes in input prices, which either compress margins or necessitate price hikes, reducing competitiveness-especially in markets dominated by cost-sensitive generics. These fluctuations can disrupt supply continuity and affect global pricing structures for Penicillin G Sodium formulations.

Key Market Trends

Expansion of Contract Manufacturing Organizations (CMOs)

A prominent trend shaping the Penicillin G Sodium market is the growing role of Contract Manufacturing Organizations (CMOs). In 2024, CMOs and CDMOs are expected to experience a growth rate of 13.8%-second only to bioprocessing segments-highlighting their increasing importance in the pharmaceutical supply chain. These organizations provide pharmaceutical companies with cost-effective production solutions, allowing firms to reduce capital expenditures on specialized equipment and compliance infrastructure. Outsourcing to CMOs is particularly advantageous for generic drug makers aiming to maintain competitiveness in highly regulated and price-sensitive markets. The scalability, operational efficiency, and regulatory alignment offered by CMOs are driving their adoption, especially for antibiotic manufacturing.

Key Market Players

  • North China Pharmaceutical Company Ltd.
  • Henan Xinxiang Huaxing Pharmaceutical
  • CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
  • Shandong Lukang Pharmaceutical Group Co., Ltd.
  • Kangyuan Pharmaceutical Group
  • Harbin Pharmaceutical Group

Report Scope

In this report, the Global Penicillin G Sodium Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Penicillin G Sodium Market, By Sales Channel:

  • Direct
  • Indirect

Penicillin G Sodium Market, By End Use:

  • Bacterial Infections
  • Syphilis
  • Prophylaxis
  • Meningitis
  • Combination Therapies
  • Others

Penicillin G Sodium Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Penicillin G Sodium Market.

Available Customizations

Global Penicillin G Sodium Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Penicillin G Sodium Market

5. Global Penicillin G Sodium Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Sales Channel (Direct, Indirect)
    • 5.2.2. By End Use (Bacterial Infections, Syphilis, Prophylaxis, Meningitis, Combination Therapies, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Penicillin G Sodium Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Sales Channel
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Penicillin G Sodium Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Sales Channel
        • 6.3.1.2.2. By End Use
    • 6.3.2. Mexico Penicillin G Sodium Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Sales Channel
        • 6.3.2.2.2. By End Use
    • 6.3.3. Canada Penicillin G Sodium Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Sales Channel
        • 6.3.3.2.2. By End Use

7. Europe Penicillin G Sodium Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Sales Channel
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Penicillin G Sodium Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Sales Channel
        • 7.3.1.2.2. By End Use
    • 7.3.2. Germany Penicillin G Sodium Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Sales Channel
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Penicillin G Sodium Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Sales Channel
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Penicillin G Sodium Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Sales Channel
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Penicillin G Sodium Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Sales Channel
        • 7.3.5.2.2. By End Use

8. Asia Pacific Penicillin G Sodium Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Sales Channel
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Penicillin G Sodium Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Sales Channel
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Penicillin G Sodium Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Sales Channel
        • 8.3.2.2.2. By End Use
    • 8.3.3. South Korea Penicillin G Sodium Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Sales Channel
        • 8.3.3.2.2. By End Use
    • 8.3.4. Japan Penicillin G Sodium Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Sales Channel
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Penicillin G Sodium Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Sales Channel
        • 8.3.5.2.2. By End Use

9. South America Penicillin G Sodium Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Sales Channel
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Penicillin G Sodium Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Sales Channel
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Penicillin G Sodium Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Sales Channel
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Penicillin G Sodium Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Sales Channel
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Penicillin G Sodium Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Sales Channel
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Penicillin G Sodium Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Sales Channel
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Penicillin G Sodium Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Sales Channel
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Penicillin G Sodium Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Sales Channel
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Penicillin G Sodium Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. North China Pharmaceutical Company.Ltd
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Henan Xinxiang Huaxing Pharmaceutical
  • 15.3. CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD.
  • 15.4. Shandong Lukang Pharmaceutical Group Co., Ltd.
  • 15.5. Kangyuan Pharmaceutical Group
  • 15.6. Harbin Pharmaceutical Group

16. Strategic Recommendations

17. About Us & Disclaimer